Truepill, a business-to-business telemedicine platform that enables healthcare brands to deliver medication, birth control, and other prescription pills directly to customers, closed a $75 million

Truepill, a business-to-business telemedicine platform that enables healthcare brands to deliver medication, birth control, and other prescription pills directly to customers, closed a $75 million
Well Health Technologies, an operator of virtual care clinics in British Columbia, agreed to acquire a majority stake in telehealth company Circle Medical, for $14
Despite widespread COVID-19 pandemic, digital health companies worldwide raised a record of $6.3 billion in the first half (1H) of 2020. Eighty percent of the
Consumer Medical, a clinic-decision-support, and second-opinions company acquired InfiniteMD, a virtual-specialist medical-opinion platform. The terms of the transaction were not disclosed. Founded by Harvard physicians
Lyra Health, a provider of mental health benefits for employers, raised $110 million in Series D financing round. Addition led the financing round. Other investors
Google’s cloud division announced a $100 million strategic investment in Amwell (formerly American Well). Amwell provides a telehealth software platform to healthcare providers and systems.
Carrot Fertility, a provider of virtual fertility benefits programs for large employers, raised $24 million in Series B funding. The funding round brings the total
Thirty Madison, a New York-based telehealth company, focusing on treating chronic health conditions, raised $47 million Series B funding. Polaris Partners led the funding with
Eden Health, a direct-to-employer telehealth platform, raised $25 million in Series B funding. The company partners with employers to offer telehealth services to their employees.
Cecelia Health, a provider of telehealth services for diabetes and other chronic diseases, completed a $13 million Series B funding round. Rittenhouse Ventures and Endo